Job Watch

EMBL: Software developer: German Human Genome-Phenome Archive (GHGA)

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: Software developer: German Human Genome-Phenome Archive (GHGA) Germany (DE)
Categories: Job Watch

EMBL: European COVID-19 Data Platform Project Manager

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: European COVID-19 Data Platform Project Manager Loca Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Scientific Product Manager: ELIXIR Human Genomics and Translational Data

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: Scientific Product Manager: ELIXIR Human Genomics and Translational Data Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Head of Research

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: Head of Research Location: EMBL- Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: BioImage Archive Team Leader

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: BioImage Archive Team Leader Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Group Leader – Computational Biology/Bioinformatics

New Scientist - Bioinformatics - Fri, 2020-09-11 07:46
Competitive Salary: EMBL: Group Leader – Computational Biology/Bioinformatics Germany (DE)
Categories: Job Watch

EMBL: Agricultural Genomics and Bioinformatics Team Leader

New Scientist - Bioinformatics - Fri, 2020-09-11 07:45
Competitive Salary: EMBL: Agricultural Genomics and Bioinformatics Team Leader Cambridge, Cambridgeshire, England
Categories: Job Watch

Notice of Limited Availability of Research Non-human Primates

Notice NOT-OD-20-173 from the NIH Guide for Grants and Contracts

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Funding Opportunity PAR-20-300 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric ?precision therapeutics.

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Funding Opportunity PAR-20-299 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.

Post Doc Res Assoc - University of Wyoming - Laramie, WY

Indeed.com - Bioinformatics - Thu, 2020-09-10 22:15
Molecular laboratory and bioinformatic analysis skills. Complete the online application and upload a single PDF file containing a cover letter, CV, academic… $50,000 a year
From University of Wyoming - Fri, 11 Sep 2020 02:15:41 GMT - View all Laramie, WY jobs
Categories: Job Watch

Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Centers (U01 Clinical Trial Required)

Funding Opportunity RFA-DK-20-506 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to solicit applications from current USDRN Clinical Centers to complete these clinical investigations.

Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required)

Funding Opportunity RFA-DK-20-507 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the current USDRN Scientific Data Research Center to complete these clinical investigations.

Reminder: NIH Natural Disaster Policy Hurricane Laura

Notice NOT-OD-20-172 from the NIH Guide for Grants and Contracts

Pages

Subscribe to Anil Jegga aggregator - Job Watch